Advanced search Help
Searching for terms: EXACT: "COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity" in: series
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 1 [January 9, 2021]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] circulation, associated illnesses, and hospitalizations decreased or remained stable but elevated during the week ending January 9, 2021. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) increased during the most recent week after declining for three weeks. Recent declines in hospitalization rates and PIC mortality should be interpreted with caution as reporting delays increased during the holidays and the downward trends may change as more data are received."
Centers for Disease Control and Prevention (U.S.)
2021-01-09
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 52 [December 26, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] circulation and associated illnesses declined or remained stable during the week ending December 26, 2020; however, there were regional differences. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) has been increasing since early October. Both COVID-19-associated hospitalizations and PIC mortality for the most recent weeks are expected to increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-12-26
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 51 [December 19, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] circulation and associated illnesses declined or remained stable during the week ending December 19, 2020. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) has been increasing since early October. Both COVID-19- associated hospitalizations and PIC mortality for the most recent weeks are expected to increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-12-19
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 50 [December 12, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] circulation and associated illnesses declined slightly or remained stable during the week ending December 12, 2020. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) has been increasing since October. Both COVID-19-associated hospitalizations and PIC mortality for the most recent weeks are expected to increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-12-12
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 49 [December 5, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] circulation and associated illnesses have been increasing since September; however, the percentage of emergency department (ED) visits for COVID [coronavirus disease 2019]-like illness (CLI) decreased slightly during week 49. The percentage of deaths due to pneumonia, influenza and COVID-19 (PIC) has been increasing since October. Both COVID-19-associated hospitalizations and PIC mortality for the most recent weeks are expected to increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-12-05
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 48 [November 28, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus circulation and associated illnesses have been increasing since September. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) increased during October and through mid-November. Both COVID-19-associated hospitalizations and PIC mortality for the most recent weeks are expected to increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-11-28
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 47 [November 21, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus circulation and associated illnesses have been increasing since September; however, the percentage of specimens testing positive for SARSCoV-2 decreased slightly during week 47. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) increased during October and early November. Both COVID-19-associated hospitalizations and PIC mortality for the most recent weeks are expected to increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-11-21
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 46 [November 14, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus circulation and associated illnesses have been increasing since September. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) increased throughout the month of October. Both COVID-19 related hospitalizations and PIC mortality for the most recent weeks are expected to increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-11-14
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 45 [November 7, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus circulation and associated illnesses have been increasing since September. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) increased during the first three weeks of October. Both COVID-19 related hospitalizations and PIC mortality for the most recent weeks may increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-11-07
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 44 [October 31, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus circulation and associated illnesses have been increasing since September. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) increased during the first two weeks of October. Both COVID-19 related hospitalizations and PIC mortality for the most recent weeks may increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-10-31
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 43 [October 24, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus circulation and associated illnesses have been increasing since September. The percentage of deaths due to pneumonia, influenza and COVID-19 [coronavirus disease 2019] (PIC) remained at approximately equal levels from mid-September through mid-October. Both COVID-19 related hospitalizations and PIC mortality for the most recent weeks may increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-10-24
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 42 [October 17, 2020]
From the Key Updates: "Nationally, surveillance indicators tracking levels of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus circulation and associated illnesses have been increasing since September, driven primarily by activity in the Southeastern and Central parts of the country. COVID-19 [coronavirus disease 2019] related hospitalization rates and pneumonia, influenza and COVID-19 (PIC) mortality for the most recent weeks may increase as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-10-17
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 41 [October 10, 2020]
From the Document: "Nationally, the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] and the percentage of visits to emergency departments (ED) or outpatient providers for COVID[coronavirus disease 2019]-like illness (CLI) and influenza-like illness (ILI) have increased slightly in recent weeks. COVID-19 related hospitalizations and mortality attributed to COVID-19 remained stable or declined but this may change as more data are received."
Centers for Disease Control and Prevention (U.S.)
2020-10-10
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 40, [October 3, 2020]
From the Document: "Nationally, indicators that track COVID-19 [coronavirus disease 2019] activity continued to decline or remain stable (change of ≤0.1%). However, one region reported a slight increase in the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] and four regions reported slight increases in the percentage of visits for influenza-like illness (ILI). Mortality attributed to COVID-19 declined but remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-10-03
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 39 [September 26, 2020]
From the Document: "Nationally, indicators that track COVID-19 [coronavirus disease 2019] activity continued to decline or remain stable (change of ≤0.1%); however, three regions reported an increase in the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus causing COVID-19, and two of those regions also reported an increase in the percentage of visits for influenza-like illness (ILI) or COVID-like illness (CLI) to emergency departments (EDs) or outpatient providers. Mortality attributed to COVID-19 declined but remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-09-26
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 38 [September 19, 2020]
From the Key Updates: "Nationally, indicators that track COVID-19 [coronavirus sidease 2019] activity continued to decline or remain stable (change of ≤0.1%); however, three regions reported an increase in the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus causing COVID-19, and one of those regions also reported an increase in the percentage of visits for influenza-like illness (ILI) and COVID-like illness (CLI) to emergency departments (EDs). Mortality attributed to COVID-19 declined but remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-09-19
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 37 [September 12, 2020]
From the Key Updates: "Nationally, indicators that track COVID-19 [coronavirus disease 2019] activity continued to decline or remain stable (change of ≤0.1%); however, two regions reported a slight increase in the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus causing COVID-19, and four regions reported a slight increase in the percent of visits for influenza-like illness (ILI) to outpatient providers or emergency departments (EDs). Mortality attributed to COVID-19 declined but remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-09-12
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 36 [September 5, 2020]
From the Key Updates: "After declining since mid-July, the percentage of laboratory specimen testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] nationally increased slightly during week 35 but then decreased during week 36. Indicators that track influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) continued to decrease or remain stable (change of ≤0.1%) nationally and in all 10 regions; however, due to COVID-19 activity, one region reported levels of ILI above the region-specific baseline. Weekly hospitalization rates and mortality attributed to COVID19 declined during week 36. Mortality attributed to COVID-19 remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-09-05
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 35 [August 29, 2020]
From the Key Updates: "After declining since mid-July, the percentage of laboratory tests positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] nationally increased slightly from week 34 to week 35; seven of ten regions also reported increases in the percentage of laboratory tests positive for SARS-CoV-2 during week 35. Indicators that track influenza-like illness (ILI) and COVID-19-like [coronavirus disease 2019-like] illness (CLI) continued to decrease or remain stable (change of ≤0.1%) nationally and in all ten regions. Weekly hospitalization rates and mortality attributed to COVID-19 declined during week 35. Mortality attributed to COVID-19 remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-08-29
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 34 [August 22, 2020]
From the Key Updates: "Indicators that track influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of laboratory tests positive for SARS-CoV-2 [severe acute respiratory syndrome 2] have continued to decrease nationally since mid-July. Regionally, from week 33 to week 34, six of ten regions reported decreasing or stable (change of ≤0.1%) ILI, CLI, and percentage of laboratory tests positive for SARS-CoV-2; however, two regions reported an increase in the percentage of specimens testing positive for SARS-CoV-2, and two regions reported an increase in ILI visits. Weekly hospitalization rates and mortality attributed to COVID-19 declined during week 34. Mortality attributed to COVID-19 remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-08-22
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 33 [August 15, 2020]
From the Key Updates: "Nationally, levels of influenza-like illness (ILI) are below baseline but higher than typically seen at this time of year. Indicators that track ILI and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of laboratory tests positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] have continued to decrease nationally since mid-July. Regionally, from week 32 to week 33, indicators that track ILI were decreasing or stable (change of ≤0.1%) in nine of ten regions of the country, an indicator that tracks CLI decreased in all regions, and the percentage of laboratory tests positive for SARS-CoV-2 decreased or remained the same in nine of ten regions. Weekly hospitalization rates and mortality attributed to COVID-19 declined during week 33 but may change as more data for admissions and deaths occurring during recent weeks are received. Mortality attributed to COVID-19 remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-08-15
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 32 [August 8, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) are below baseline but higher than typically seen at this time of year. Indicators that track ILI and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of laboratory tests positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] have continued to decrease nationally since mid-July. Regionally, from week 31 to week 32, indicators that track ILI and COVID-19-like illness (CLI) were decreasing or stable (change of ≤ 0.1%) in all regions of the country, and the percentage of laboratory tests positive for SARS-CoV-2 decreased or remained the same in nine of ten HHS regions. Weekly hospitalization rates and mortality attributed to COVID-19 declined during week 32 but may change as more data for admissions and deaths occurring during recent weeks are received. Mortality attributed to COVID-19 remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-08-08
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 31 [August 1, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) are below baseline but higher than typically seen at this time of year. Indicators that track ILI and COVID-19 [coronavirus disease 2019]-like illness (CLI) showed decreases nationally from week 30 to week 31, with decreasing or stable (change of ≤ 0.1%) levels in all regions of the country. Nationally, the percentage of laboratory tests positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] decreased from week 30 to week 31 and decreased in nine of ten HHS [United States Department of Health and Human Services] regions. Weekly hospitalization rates and mortality attributed to COVID-19 declined during week 31 but may change as more data for admissions and deaths occurring during the most recent weeks are received. Mortality attributed to COVID-19 remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-08-01
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 30 [July 25, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) are below baseline but higher than typically seen at this time of year. Indicators that track ILI and COVID-19 [coronavirus disease 2019]-like illness (CLI) showed decreases nationally from week 29 to week 30, with decreasing or stable levels in nearly all regions of the country. Nationally, the percentage of laboratory tests positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] remained stable from week 29 to week 30 but increased in six of ten HHS [U.S. Department of Health and Human Services] regions. Weekly hospitalization rates and mortality attributed to COVID-19 declined during week 30 but may change as more data for admissions and deaths occurring during the most recent weeks are received. Mortality attributed to COVID-19 remains above the epidemic threshold."
Centers for Disease Control and Prevention (U.S.)
2020-07-25
-
COVIDview: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 29 [July 18, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) are below baseline, but higher than typically seen at this time of year. Indicators that track COVID-19 [coronavirus disease 2019]-like illness (CLI) and laboratory confirmed SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] showed decreases from week 28 to week 29 nationally; however, there were regional differences. Areas of the country with high levels of CLI and laboratory confirmed SARS-CoV-2 in recent weeks (Regions 4 [South East], 6 [South Central] and 9 [South West/ Coast]) are starting to show signs of decreasing activity whereas other parts of the country (Regions 7 [Midwest], 5 [Central] and 8 [Mountain]) are increasing. Hospitalization rates show an increasing trend. Mortality attributed to COVID-19 remains above the epidemic threshold and increased slightly during the first two weeks of July after declining for 11 weeks since mid-April."
Centers for Disease Control and Prevention (U.S.)
2020-07-18
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 28 [July 11, 2020]
From the Key Updates: "Nationally, levels of influenza-like illness (ILI) are low overall, but high for this time of year. Changes in indicators that track COVID-19 [coronavirus disease 2019]-like illness (CLI) and laboratory confirmed SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] were inconsistent during the most recent week, with some increasing but others decreasing. This could be due to changes in healthcare seeking behavior around the holiday that occurred during week 27. However, in several regions, those indicators increased compared to the previous week (week 26), suggesting an increasing trend in many areas of the country. Hospitalizations rates, which typically lag behind illness indicators, show an increasing trend. Mortality attributed to COVID-19 decreased compared to last week but is currently above the epidemic threshold and will likely increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-07-16
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 27 [July 4, 2020]
From the Key Updates: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) activity continue to increase overall. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, decreased slightly from last week; however, this past week included a holiday, which could impact both testing and reporting. Mortality attributed to COVID-19 decreased compared to last week and is currently at the epidemic threshold but will likely increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-07-09
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 26 [June 27, 2020]
From the Key Updates: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) activity remain lower than peaks seen in March and April but are increasing in most regions. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, also increased from last week. Mortality attributed to COVID-19 decreased compared to last week and is currently at the epidemic threshold but will likely increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-07-02
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 25 [June 20, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) remain lower than peaks seen in March and April but are increasing in several regions. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, also increased from last week. Mortality attributed to COVID-19 decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-06-20
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 24 [June 13, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) remain lower than peaks seen in March and April but are increasing slightly in some regions. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, also increased slightly from last week in some regions. Mortality attributed to COVID-19 decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-06-13
